![](/images/graphics-bg.png)
Immunotherapy of Genitourinary Malignancies
Joint Authors
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-03-05
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
Most cancer patients are treated with some combination of surgery, radiation, and chemotherapy.
Despite recent advances in local therapy with curative intent, chemotherapeutic treatments for metastatic disease often remain unsatisfying due to severe side effects and incomplete long-term remission.
Therefore, the evaluation of novel therapeutic options is of great interest.
Conventional, along with newer treatment strategies target the immune system that suppresses genitourinary (GU) malignancies.
Metastatic renal cell carcinoma and non-muscle-invasive bladder caner represent the most immune-responsive types of all human cancer.
This review examines the rationale and emerging evidence supporting the anticancer activity of immunotherapy, against GU malignancies.
American Psychological Association (APA)
Inamoto, Teruo& Azuma, Haruhito. 2012. Immunotherapy of Genitourinary Malignancies. Journal of Oncology،Vol. 2012, no. 2012, pp.1-8.
https://search.emarefa.net/detail/BIM-468920
Modern Language Association (MLA)
Inamoto, Teruo& Azuma, Haruhito. Immunotherapy of Genitourinary Malignancies. Journal of Oncology No. 2012 (2012), pp.1-8.
https://search.emarefa.net/detail/BIM-468920
American Medical Association (AMA)
Inamoto, Teruo& Azuma, Haruhito. Immunotherapy of Genitourinary Malignancies. Journal of Oncology. 2012. Vol. 2012, no. 2012, pp.1-8.
https://search.emarefa.net/detail/BIM-468920
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-468920